(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Emerging Growth Company |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL) |
Applied Materials, Inc. (Registrant) | ||||||||||||||
Date: | May 14, 2020 | By: | /s/ Christina Y. Lai | |||||||||||
Christina Y. Lai | ||||||||||||||
Corporate Secretary |
Q2 FY2020 | Q2 FY2019 | Change | |||||||||||||||
(In millions, except per share amounts and percentages) | |||||||||||||||||
Net sales | $ | 3,957 | $ | 3,539 | 12% | ||||||||||||
Gross margin | 44.2 | % | 43.2 | % | 1.0 points | ||||||||||||
Operating margin | 23.6 | % | 21.9 | % | 1.7 points | ||||||||||||
Net income | $ | 755 | $ | 666 | 13% | ||||||||||||
Diluted earnings per share | $ | 0.82 | $ | 0.70 | 17% | ||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||
Non-GAAP adjusted gross margin | 44.6 | % | 43.5 | % | 1.1 points | ||||||||||||
Non-GAAP adjusted operating margin | 24.7 | % | 22.4 | % | 2.3 points | ||||||||||||
Non-GAAP adjusted net income | $ | 817 | $ | 660 | 24% | ||||||||||||
Non-GAAP adjusted diluted EPS | $ | 0.89 | $ | 0.70 | 27% |
Semiconductor Systems | Q2 FY2020 | Q2 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 2,567 | $ | 2,184 | |||||||
Foundry, logic and other | 56 | % | 58 | % | |||||||
DRAM | 22 | % | 18 | % | |||||||
Flash memory | 22 | % | 24 | % | |||||||
Operating income | 782 | 579 | |||||||||
Operating margin | 30.5 | % | 26.5 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 798 | $ | 589 | |||||||
Non-GAAP adjusted operating margin | 31.1 | % | 27.0 | % |
Applied Global Services | Q2 FY2020 | Q2 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 1,018 | $ | 984 | |||||||
Operating income | 256 | 283 | |||||||||
Operating margin | 25.1 | % | 28.8 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 260 | $ | 283 | |||||||
Non-GAAP adjusted operating margin | 25.5 | % | 28.8 | % |
Display and Adjacent Markets | Q2 FY2020 | Q2 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 365 | $ | 348 | |||||||
Operating income | 75 | 42 | |||||||||
Operating margin | 20.5 | % | 12.1 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 78 | $ | 46 | |||||||
Non-GAAP adjusted operating margin | 21.4 | % | 13.2 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | April 26, 2020 | April 28, 2019 | April 26, 2020 | April 28, 2019 | |||||||||||||||||||
Net sales | $ | 3,957 | $ | 3,539 | $ | 8,119 | $ | 7,292 | |||||||||||||||
Cost of products sold | 2,208 | 2,009 | 4,512 | 4,097 | |||||||||||||||||||
Gross profit | 1,749 | 1,530 | 3,607 | 3,195 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research, development and engineering | 550 | 508 | 1,102 | 1,024 | |||||||||||||||||||
Marketing and selling | 130 | 133 | 265 | 264 | |||||||||||||||||||
General and administrative | 137 | 113 | 266 | 223 | |||||||||||||||||||
Total operating expenses | 817 | 754 | 1,633 | 1,511 | |||||||||||||||||||
Income from operations | 932 | 776 | 1,974 | 1,684 | |||||||||||||||||||
Interest expense | 61 | 60 | 120 | 120 | |||||||||||||||||||
Interest and other income, net | 7 | 43 | 29 | 83 | |||||||||||||||||||
Income before income taxes | 878 | 759 | 1,883 | 1,647 | |||||||||||||||||||
Provision for income taxes | 123 | 93 | 236 | 210 | |||||||||||||||||||
Net income | $ | 755 | $ | 666 | $ | 1,647 | $ | 1,437 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 0.82 | $ | 0.71 | $ | 1.80 | $ | 1.51 | |||||||||||||||
Diluted | $ | 0.82 | $ | 0.70 | $ | 1.78 | $ | 1.50 | |||||||||||||||
Weighted average number of shares: | |||||||||||||||||||||||
Basic | 917 | 942 | 917 | 950 | |||||||||||||||||||
Diluted | 923 | 948 | 925 | 957 |
(In millions) | April 26, 2020 | October 27, 2019 | |||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 5,281 | $ | 3,129 | |||||||
Short-term investments | 423 | 489 | |||||||||
Accounts receivable, net | 2,625 | 2,533 | |||||||||
Inventories | 3,725 | 3,474 | |||||||||
Other current assets | 681 | 581 | |||||||||
Total current assets | 12,735 | 10,206 | |||||||||
Long-term investments | 1,678 | 1,703 | |||||||||
Property, plant and equipment, net | 1,534 | 1,529 | |||||||||
Goodwill | 3,426 | 3,399 | |||||||||
Purchased technology and other intangible assets, net | 132 | 156 | |||||||||
Deferred income taxes and other assets | 2,310 | 2,031 | |||||||||
Total assets | $ | 21,815 | $ | 19,024 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | 600 | $ | 600 | |||||||
Accounts payable and accrued expenses | 2,831 | 2,511 | |||||||||
Contract liabilities | 1,334 | 1,336 | |||||||||
Total current liabilities | 4,765 | 4,447 | |||||||||
Long-term debt, net of current portion | 6,215 | 4,713 | |||||||||
Income taxes payable | 1,238 | 1,275 | |||||||||
Other liabilities | 573 | 375 | |||||||||
Total liabilities | 12,791 | 10,810 | |||||||||
Total stockholders’ equity | 9,024 | 8,214 | |||||||||
Total liabilities and stockholders’ equity | $ | 21,815 | $ | 19,024 |
(In millions) | Three Months Ended | Six Months Ended | |||||||||||||||||||||
April 26, 2020 | April 28, 2019 | April 26, 2020 | April 28, 2019 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ | 755 | $ | 666 | $ | 1,647 | $ | 1,437 | |||||||||||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 91 | 94 | 185 | 182 | |||||||||||||||||||
Share-based compensation | 71 | 65 | 164 | 130 | |||||||||||||||||||
Deferred income taxes | (11) | 8 | 19 | 49 | |||||||||||||||||||
Other | 7 | (10) | 22 | (9) | |||||||||||||||||||
Net change in operating assets and liabilities | (278) | (23) | (415) | (155) | |||||||||||||||||||
Cash provided by operating activities | 635 | 800 | 1,622 | 1,634 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Capital expenditures | (71) | (118) | (173) | (251) | |||||||||||||||||||
Cash paid for acquisitions, net of cash acquired | (27) | (23) | (27) | (23) | |||||||||||||||||||
Proceeds from sales and maturities of investments | 667 | 442 | 1,035 | 906 | |||||||||||||||||||
Purchases of investments | (404) | (430) | (832) | (827) | |||||||||||||||||||
Cash provided by (used in) investing activities | 165 | (129) | 3 | (195) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Debt borrowings, net of issuance costs | 1,498 | — | 1,498 | — | |||||||||||||||||||
Proceeds from common stock issuances | 76 | 73 | 91 | 73 | |||||||||||||||||||
Common stock repurchases | (199) | (625) | (399) | (1,375) | |||||||||||||||||||
Tax withholding payments for vested equity awards | (10) | (6) | (163) | (80) | |||||||||||||||||||
Payments of dividends to stockholders | (193) | (189) | (385) | (381) | |||||||||||||||||||
Cash provided by (used in) financing activities | 1,172 | (747) | 642 | (1,763) | |||||||||||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | 1,972 | (76) | 2,267 | (324) | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 3,424 | 3,192 | 3,129 | 3,440 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 5,396 | $ | 3,116 | $ | 5,396 | $ | 3,116 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ | 5,281 | $ | 3,116 | $ | 5,281 | $ | 3,116 | |||||||||||||||
Restricted cash equivalents included in deferred income taxes and other assets | 115 | — | 115 | — | |||||||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 5,396 | $ | 3,116 | $ | 5,396 | $ | 3,116 | |||||||||||||||
Supplemental cash flow information: | |||||||||||||||||||||||
Cash payments for income taxes | $ | 199 | $ | 198 | $ | 281 | $ | 232 | |||||||||||||||
Cash refunds from income taxes | $ | 4 | $ | 10 | $ | 5 | $ | 18 | |||||||||||||||
Cash payments for interest | $ | 76 | $ | 76 | $ | 110 | $ | 110 |
(In millions) | Q2 FY2020 | Q2 FY2019 | |||||||||
Unallocated net sales | $ | 7 | $ | 23 | |||||||
Unallocated cost of products sold and expenses | (117) | (86) | |||||||||
Share-based compensation | (71) | (65) | |||||||||
Total | $ | (181) | $ | (128) |
Q2 FY2020 | Q2 FY2019 | ||||||||||
Net Sales by Geography (In millions) | |||||||||||
United States | 331 | 457 | |||||||||
% of Total | 8 | % | 13 | % | |||||||
Europe | 181 | 215 | |||||||||
% of Total | 5 | % | 6 | % | |||||||
Japan | 467 | 520 | |||||||||
% of Total | 12 | % | 15 | % | |||||||
Korea | 753 | 441 | |||||||||
% of Total | 19 | % | 13 | % | |||||||
Taiwan | 1,029 | 794 | |||||||||
% of Total | 26 | % | 22 | % | |||||||
Southeast Asia | 58 | 119 | |||||||||
% of Total | 1 | % | 3 | % | |||||||
China | 1,138 | 993 | |||||||||
% of Total | 29 | % | 28 | % | |||||||
Employees (In thousands) | |||||||||||
Regular Full Time | 22.7 | 21.4 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | April 26, 2020 | April 28, 2019 | April 26, 2020 | April 28, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||||||||||
Reported gross profit - GAAP basis | $ | 1,749 | $ | 1,530 | $ | 3,607 | $ | 3,195 | |||||||||||||||
Certain items associated with acquisitions1 | 8 | 9 | 17 | 19 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 8 | — | 8 | — | |||||||||||||||||||
Non-GAAP adjusted gross profit | $ | 1,765 | $ | 1,539 | $ | 3,632 | $ | 3,214 | |||||||||||||||
Non-GAAP adjusted gross margin | 44.6 | % | 43.5 | % | 44.7 | % | 44.1 | % | |||||||||||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 932 | $ | 776 | $ | 1,974 | $ | 1,684 | |||||||||||||||
Certain items associated with acquisitions1 | 13 | 14 | 26 | 28 | |||||||||||||||||||
Acquisition integration and deal costs | 21 | 4 | 34 | 7 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 10 | — | 10 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 976 | $ | 794 | $ | 2,044 | $ | 1,719 | |||||||||||||||
Non-GAAP adjusted operating margin | 24.7 | % | 22.4 | % | 25.2 | % | 23.6 | % | |||||||||||||||
Non-GAAP Adjusted Net Income | |||||||||||||||||||||||
Reported net income - GAAP basis | $ | 755 | $ | 666 | $ | 1,647 | $ | 1,437 | |||||||||||||||
Certain items associated with acquisitions1 | 13 | 14 | 26 | 28 | |||||||||||||||||||
Acquisition integration and deal costs | 21 | 4 | 34 | 7 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 10 | — | 10 | — | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | 5 | (4) | 7 | (6) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | 2 | (7) | 4 | (17) | |||||||||||||||||||
Income tax effect of share-based compensation2 | 8 | 1 | (25) | (4) | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws3 | — | — | — | (24) | |||||||||||||||||||
Income tax effects related to amortization of intra-entity intangible asset transfers | 16 | (31) | 37 | (59) | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (3) | 17 | (4) | 76 | |||||||||||||||||||
Income tax effect of non-GAAP adjustments4 | (10) | — | (15) | 1 | |||||||||||||||||||
Non-GAAP adjusted net income | $ | 817 | $ | 660 | $ | 1,721 | $ | 1,439 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. | ||||
3 | Charges to income tax provision related to a one-time transition tax as a result of U.S. tax legislation. | ||||
4 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. | ||||
5 | Temporary incremental employee compensation during the COVID-19 pandemic. |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | April 26, 2020 | April 28, 2019 | April 26, 2020 | April 28, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 0.82 | $ | 0.70 | $ | 1.78 | $ | 1.50 | |||||||||||||||
Certain items associated with acquisitions | 0.01 | 0.01 | 0.02 | 0.03 | |||||||||||||||||||
Acquisition integration and deal costs | 0.02 | — | 0.04 | — | |||||||||||||||||||
Certain incremental expenses related to COVID-19 | 0.01 | — | 0.01 | — | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | 0.01 | — | 0.01 | — | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | — | — | — | (0.02) | |||||||||||||||||||
Income tax effect of share-based compensation | 0.01 | — | (0.03) | (0.01) | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws | — | — | — | (0.02) | |||||||||||||||||||
Income tax effects related to amortization of intra-entity intangible asset transfers | 0.02 | (0.03) | 0.04 | (0.06) | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (0.01) | 0.02 | (0.01) | 0.08 | |||||||||||||||||||
Non-GAAP adjusted earnings per diluted share | $ | 0.89 | $ | 0.70 | $ | 1.86 | $ | 1.50 | |||||||||||||||
Weighted average number of diluted shares | 923 | 948 | 925 | 957 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | April 26, 2020 | April 28, 2019 | April 26, 2020 | April 28, 2019 | |||||||||||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 782 | $ | 579 | $ | 1,697 | $ | 1,210 | |||||||||||||||
Certain items associated with acquisitions1 | 10 | 10 | 20 | 21 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | 6 | — | 6 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 798 | $ | 589 | $ | 1,723 | $ | 1,231 | |||||||||||||||
Non-GAAP adjusted operating margin | 31.1 | % | 27.0 | % | 32.0 | % | 27.7 | % | |||||||||||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 256 | $ | 283 | $ | 534 | $ | 568 | |||||||||||||||
Certain incremental expenses related to COVID-192 | 4 | — | 4 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 260 | $ | 283 | $ | 538 | $ | 568 | |||||||||||||||
Non-GAAP adjusted operating margin | 25.5 | % | 28.8 | % | 26.7 | % | 29.2 | % | |||||||||||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 75 | $ | 42 | $ | 113 | $ | 157 | |||||||||||||||
Certain items associated with acquisitions1 | 3 | 4 | 6 | 7 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 78 | $ | 46 | $ | 119 | $ | 164 | |||||||||||||||
Non-GAAP adjusted operating margin | 21.4 | % | 13.2 | % | 17.1 | % | 19.2 | % | |||||||||||||||
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
Three Months Ended | |||||
(In millions, except percentages) | April 26, 2020 | ||||
Provision for income taxes - GAAP basis (a) | $ | 123 | |||
Income tax effect of share-based compensation | (8) | ||||
Income tax effects related to amortization of intra-entity intangible asset transfers | (16) | ||||
Resolutions of prior years’ income tax filings and other tax items | 3 | ||||
Income tax effect of non-GAAP adjustments | 10 | ||||
Non-GAAP adjusted provision for income taxes (b) | $ | 112 | |||
Income before income taxes - GAAP basis (c) | $ | 878 | |||
Certain items associated with acquisitions | 13 | ||||
Acquisition integration and deal costs | 21 | ||||
Certain incremental expenses related to COVID-19 | 10 | ||||
Realized loss (gain) on strategic investments, net | 5 | ||||
Unrealized loss (gain) on strategic investments, net | 2 | ||||
Non-GAAP adjusted income before income taxes (d) | $ | 929 | |||
Effective income tax rate - GAAP basis (a/c) | 14.0 | % | |||
Non-GAAP adjusted effective income tax rate (b/d) | 12.1 | % |